Drug Shortage Report for NIDAGEL

Last updated on 2023-01-25 History
Report ID 174138
Drug Identification Number 02125226
Brand name NIDAGEL
Common or Proper name NIDAGEL
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) METRONIDAZOLE
Strength(s) 0.75%
Dosage form(s) GEL
Route of administration VAGINAL VAGINAL
Packaging size 70g
ATC code G01AF
ATC description ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-11-21
Actual start date 2022-11-04
Estimated end date 2023-01-26
Actual end date 2023-01-23
Shortage status Resolved
Updated date 2023-01-25
Company comments Capacity Problem in Production
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-09 English Compare
v2 2022-11-09 French Compare
v3 2022-11-17 English Compare
v4 2022-11-17 French Compare
v5 2022-12-21 English Compare
v6 2022-12-21 French Compare
v7 2023-01-11 English Compare
v8 2023-01-11 French Compare
v9 2023-01-25 English Compare
v10 2023-01-25 French Compare

Showing 1 to 10 of 10